Who owns PELTHOS THERAPEUTICS INC?
- Ticker: PTHS
- CUSIP Number: 171126204
Tip: Access positions for across all investors
Analyze quarterly positions in Pelthos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pelthos Therapeutics stock
Who bought or sold PELTHOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Murchinson | 296k | $6.2M | 2% | Mar 2026 |
|
| Ikarian Capital | 257k | $5.4M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 93k | $2.0M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 82k | $1.7M | 1% | Mar 2026 |
|
| J. Goldman & Co | 78k | $2.4M | 100% | Dec 2025 |
|
| Vanguard Group | 75k | $2.3M | 12% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 41k | $870k | 18% | Mar 2026 |
|
| Diadema Partners | 25k | $775k | 138% | Dec 2025 |
|
| Knott David M Jr | 21k | $443k | 9% | Mar 2026 |
|
| Geode Capital Management | 15k | $321k | 12% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 9.8k | $206k | 100% | Mar 2026 |
|
| Pale Fire Capital SE | 8.1k | $251k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 6.0k | $126k | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 1.9k | $40k | 0% | Mar 2026 |
|
| UBS Group | 764.00 | $16k | 76% | Mar 2026 |
|
| Farther Finance Advisors | 40.00 | $852.000000 | 100% | Mar 2026 |
|
| Aspect Partners | 16.00 | $336.000000 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $21.000000 | 100% | Mar 2026 |
|
Who sold out of Pelthos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2025 | 11k | $343k |
| Tower Research Capital | Sep 2025 | 827.00 | $23k |
| Jpmorgan Chase & Co | Sep 2025 | 1.00 | $28.000000 |